Private EquityRIA · CRD 331630SEC-RegisteredPrivate Fund Adviser

Updated:

Isomer Capital

Joe Schorge founded Isomer Capital in 2015 after more than two decades allocating to private markets, including roles at SVG Capital and Pomona Capital.

Isomer Capital logo

Isomer Capital

Joe Schorge founded Isomer Capital in 2015 after more than two decades allocating to private markets, including roles at SVG Capital and Pomona Capital. The London-based firm was purpose-built to channel institutional capital into European venture, a market Schorge viewed as under-allocated relative to the weight of innovation coming out of cities like London, Berlin, Stockholm, and Paris. Isomer operates independently and raises commingled funds alongside bespoke separate accounts for LPs that include pension funds, insurers, and family offices across Europe and Asia. Isomer executes through two primary sleeves: primary fund commitments to early-stage and growth-stage venture managers, and a dedicated secondary program that acquires LP interests in venture funds and portfolios. The firm targets generalist and sector-focused funds across enterprise software, fintech, AI/ML, and digital health. Schorge has publicly stated that Isomer intentionally concentrates its primary commitments with a small number of repeat managers — a conviction-over-spread approach that differentiates it from the scatter-shot FoFs of the 2000s. The secondary book lets the firm acquire positions in growth-stage companies like Revolut, TransferWise, and Graphcore well after the original fund vintages have closed, creating a backdoor to assets that rarely appear in primary fundraises. The firm's scale remains tightly held; Isomer does not disclose a public AUM figure nor a headcount. Its public footprint consists of a lean website and sparse media appearances. Schorge occasionally speaks at LP/GP conferences such as SuperReturn and the BVCA's venture forums, where he argues for portfolio construction that weights manager relationships over volume. No adjacent philanthropic vehicles or operating companies are publicly tied to the firm. Isomer's structural distinction lies in its deliberate focus on European venture's access problem. US LPs in particular have historically struggled to write meaningful checks into funds like Seedcamp, Northzone, or LocalGlobe without a local intermediary. Isomer serves as that intermediary — but unlike a placement agent or a fund-of-funds aggregator that simply parcels out commitments, the firm uses its secondary desk to compound exposure into the winners of those portfolios, effectively running a concentrated re-up strategy on the best-performing underlying companies.

General information

Firm type

Private Equity

Year founded

2015

AUM

Undisclosed

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

London, United Kingdom

Principals

Joe Schorge

Managing Partner

Sector focus

Enterprise SoftwareAI/MLFinTechDigital Health

Frequently asked questions

Who runs investment decisions at Isomer Capital?

Joe Schorge is the Managing Partner and drives investment decisions, drawing on more than two decades of private markets experience. Prior to founding Isomer in 2015, he was a partner at SVG Capital and held senior roles at Pomona Capital. Schorge has built a compact team, though the firm does not publicly disclose the full investment committee structure or additional partners.

How does Isomer source its primary fund commitments?

Isomer relies on Schorge's two-decade network in European venture, cultivated through prior roles and consistent LP presence at manager annual meetings. The firm targets managers that do not broadly market to institutional investors, particularly early-stage funds in London, Berlin, Stockholm, and Paris. Schorge has cited relationship density — not consultant gatekeepers or placement-agent flow — as Isomer's primary sourcing mechanism.

Does Isomer participate in fund commitments or only direct deals?

Isomer operates a hybrid model built on two distinct sleeves. The primary sleeve makes fund commitments to early-stage and growth-stage European venture managers. The secondary sleeve acquires LP interests in venture funds — and occasionally entire portfolios — giving Isomer indirect exposure to companies that have already demonstrated traction, such as Revolut and Graphcore (public record). The firm does not pursue direct co-investments as a standalone program.

What is Isomer's known posture on co-investments alongside external GPs?

Isomer does not publicly promote a direct co-investment program. Its exposure to individual companies comes through the secondary desk, which purchases LP stakes in funds that hold those positions. This creates de facto exposure to growth-stage names without the firm writing direct equity checks alongside GPs. For allocators who want pure co-investment rights, Isomer is not a natural fit — its edge is in acquiring seasoned venture assets, not originating new deals.

Which sectors does Isomer Capital explicitly target?

Isomer maintains a technology-focused mandate spanning enterprise software, fintech, artificial intelligence and machine learning, and digital health. The firm backs both generalist venture funds and sector-specialist managers within these verticals. It has not publicly declared any sectors it explicitly avoids, though its manager selection has historically stayed within technology-enabled businesses rather than hard-tech, biotech, or deep-science startups.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More London Private Equity profiles